Navigation Links
NHS to fund Herceptin treatment for Stuart weaver

Herceptin is one of a new generation drug that can treat breast cancer. But NHS said that it would fund the treatment for patients suffering from later stages of breast cancer. // Due to this there are lots of legal challenges by cancer sufferers to force their local health care providers to pay for the drug. The latest being a British man, Stuart Weaver who filed the case and won it. He was told that his local NHS trust would fund for his treatment with Herceptin. Maidstone Weald Primary Care Trust said that they have agreed only after reviewing his age, clinical needs and advice from his medical consultants.

He is 37 years old and is suffering from breast cancer. Herceptin has created lot of commotion as it attacks only cancer cells and does not pose a lot of damage to the normal ones. It is also much better than the traditional chemotherapy. Herceptin is manufactured by Switzerland's Roche and is very expensive. It costs about $37,168 a year and is licensed only for patients suffering with advanced breast cancer. But doctors can prescribe it to those patients who they feel should receive the drug for treatment. Although it is shown that Herceptin can help patients in the early stages of breast cancer health authorities respond negatively for funding the treatment in early stage breast cancer except for exceptional cases.


'"/>




Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Drug Herceptin To Be Recommended To All Breast Cancer Patients
3. Herceptin Is A Possible Cure For Breast Cancer
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. ￡6000 to be refunded to Mrs. Leese for Herceptin treatmen
6. Wangaratta Community fundraising for Herceptin drug
7. Herceptin for Early Stage Breast cancer
8. Treatment of Breast Cancer with Herceptin for Nine Weeks
9. Herceptin is the cure for early stages of breast cancer?
10. 10-year-old Pleads, Herceptin For My Mum, Please
11. Norfolk PCTs To Offer Herceptin
Post Your Comments:
(Date:7/26/2008)...device giving patients freedom of movement, better...HealthDay News) -- An automated artificial kidney ...alysis patients what the insulin pump is to diabet...al kidney (AWAK) works better than conventional di...of Clinical and Experimental Nephrology . , "W...
(Date:7/25/2008)....Y., July 25 /PRNewswire-USNewswire/ -- Anthony Sh...ty Officer and Vice President,of Strategic Plannin..., a,national foundation committed to improving U.S... foundation,s Program on Health Care Quality,Impro...m.com/cgi-bin/prnh/20080725/DC28791LOGO ), Board...
(Date:7/25/2008)...ponse after antiretroviral therapy may be due to g...thDay News) -- A new study challenges the long-hel...the immune system,s ability to restore itself afte...retroviral therapy (HAART). , From 50 percent t...nfected with HCV. Intravenous drug use is the main...
(Date:7/25/2008)...ffers patients consumers tips and encourages them ...HARRISBURG, Pa., July 25 /PRNewswire-USNewswire/ -...supports "National Patient Safety Day" which,is a ...milies to,participate fully in their healthcare by... about their surgery or illness., "We understand ...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...ith high-risk genes could increase their chances o...David Goldgar // at the International Agency for R...He found that women with BRCA1 and 2 (breast cance...had undergone a chest X-ray were 54 percent more l...
...il (ACC) and UNICEF have renewed their internation... under which they will support// the global campai...AIDS'. The two bodies will also promote the right...eation and promote girls' education in South Asia,...
...?gren’s (SHOW-grins) syndrome was found to be the ...or long periods. Typical signs and symptoms inclu...y vision, a dry mouth that causes difficulty swall...tid glands. The parotids are a pair of salivary gl...
... Clinic Health Center have identified and announce... Dermatitis, an allergic disease with red, sore it...ike chemicals, medications, certain plants, jewell...ls, creams, etc. The July issue of Mayo Clinic He...
Other Medicine News:
(Date:7/23/2008)...Body Have Greater Concentrations of,Stem Cells, A...wire/ -- Fat removed,from the lower abdomen and in...xcellent source of stem cells, with higher stem ce...ports a Brazilian-based study in August,s,Plastic ...l journal of the,American Society of Plastic Surge...
(Date:7/23/2008)...k with Protein Therapeutics that Modulat...IDGE, Mass., July 23 /- Taligen Thera...rporate growth plan with the,appointment of Abbie ...e,establishment of its headquarters in Cambridge, ...a co-founder of the company who remains president....
(Date:7/22/2008)...- Nonin Medical, a leading innovator,of physiologi...as entered,the clinical testing phase with its bre...turation. Today,s most common application for this...gional blood oxygenation,in the brain -- cerebral ...n ongoing clinical study at the,Duke University Me...
(Date:7/22/2008)...fficacy of Treating Patients with ... YONGIN-SI, South Korea, July 22 /-,J...io), and its South,Korean partner Green Cross Corp...e I clinical trial of its first-in-class lead prod...tolerated and resulted in clear,anti-cancer effica...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4USP Convention and Chinese Pharmacopoeia Commission sign Memorandum of Understanding 2430 1USP Convention and Chinese Pharmacopoeia Commission sign Memorandum of Understanding 2430 2U of I researcher develops power packed soy breakfast cereal 2428 1U of I researcher develops power packed soy breakfast cereal 2428 2AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 1AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 2AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 3United Mitochondrial Disease Foundation Statement on Vaccines Autism and Mitochondrial Disease 13708 1
...e People with Diabetes, Hospital,and Professional ...PITTSBURGH, April 02, 2007 /PRNewswire-FirstCall/ ...announced today the,release of a new report on the...with Type 2 diabetes. The inaugural Pittsburgh Typ...of patient,demographics, hospital and professional...
...archers report that a,variation in a portion of DN...this common variation may be responsible for up to...in the United States.,The research was conducted b... (NCI), part of the National Institutes of Health,...of Susceptibility,(CGEMS) initiative. CGEMS resear...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 2Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 3Researchers Discover a Common Variation in a Gene Segment that,Increases the Risk for Prostate Cancer 4
Straight shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish.
Straight shafts with teeth and 6 mm crisscross serrated tying surfaces. Serrated handle with polished finish.
Straight shafts with 1 x 2 teeth. Wide serrated handle with polished finish.
Serrated, 10 mm tips angled 90 degrees. Serrated cross action handle with polished finish.
Medicine Products: